# OnCo record paper-nct03775486-j-thorac-oncol-2023 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-nct03775486-j-thorac-oncol-2023/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-nct03775486-j-thorac-oncol-2023" ;
  schema:name "Durvalumab in Combination With Olaparib Versus Durvalumab Alone as Maintenance Therapy in Metastatic NSCLC: The Phase 2 ORION Study"@en ;
  schema:description "Published report from the ORION trial registered as NCT03775486, in Journal of Thoracic Oncology (2023), chosen as the most cited paper whose own text cites the registry id."@en ;
  schema:url <https://onco.cc/key-papers/paper-nct03775486-j-thorac-oncol-2023/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/j.jtho.2023.06.013>, <https://pubmed.ncbi.nlm.nih.gov/37390980/>, <https://europepmc.org/article/MED/37390980>, <https://clinicaltrials.gov/study/NCT03775486> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/j.jtho.2023.06.013> ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "Ahn MJ, Bondarenko I, Kalinka E, et al." ;
  onco:trials <https://onco.cc/trials/nct03775486/> ;
  onco:journals <https://onco.cc/journals/journal-of-thoracic-oncology/> .
